Patheon Company Updates | Glassdoor

Company Updates

  • Michel Lagarde, President, Pharma Services sat down with The Medicine Maker to discuss the latest trends and innovations in pharmaceutical manufacturing and why Thermo Fisher Scientific is a great home for Patheon.

  • See how we are increasing capacity to meet growing customer demands through a $50 million investment in our Biologics capabilities.

    Thermo Fisher Scientific Announces $50 Million Investment to Enhance Biologics Capabilities

    ST. LOUIS, April 23, 2018 / PRNewswire/ -- Thermo Fisher Scientific announced today that is investing $50 million in its St. Louis, Missouri site which is one of the company's Centers of Excellence (COE) for Biological Commercial Manufacturing.

  • Sarah, project manager in our Pharma Services business, helped save a little boys life by making sure Thermo Fisher Scientific delivered the cutting-edge treatment he needed.

    Story - Action - Thermo Fisher

    Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of more than $20 billion and approximately 65,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer.

  • See why Thermo Fisher Scientific and Patheon employees are proud to come together to form the first truly integrated, end-to-end global CDMO (contract development and manufacturing organization) to better serve our customers.

Work at Patheon? Share Your Experiences

  • Star
  • Star
  • Star
  • Star
  • Star
Click to Rate